News

Idorsia: Breaking New Grounds in Pharmaceuticals and Finances

Idorsia: Breaking New Grounds in Pharmaceuticals and Finances

Idorsia Takes Bold Steps in Annual Report 2024

Ad hoc announcement pursuant to Art. 53 LR

Idorsia Ltd (SIX: IDIA) proudly announces the release of its Annual Report 2024, a comprehensive document integrating the Business Report, Governance Report, Compensation Report, Sustainability Report, and Financial Report.

Shareholders are reminded that the Annual General Meeting (AGM) will be convened to discuss the Annual Report for the year ending December 31, 2024.

Registered shareholders holding at least 0.5% of the company's share capital are encouraged to submit proposals for the AGM agenda. Suggestions must reach Idorsia Ltd's Corporate Secretary by the specified deadline.

To participate in the AGM, shareholders must ensure they are registered by the designated date.

Key Financial Events and Developments

In 2024, Idorsia has laid out several key financial reporting dates, including the release of the First Quarter 2025 Financial Results, the AGM, and the Half-Year 2025 Financial Results.

Letter from the Chairman

Dear Shareholders,

As the new Chairman, I want to express my gratitude for your trust in me. Our 2024 achievements reflect significant progress on multiple fronts. Notably, we've seen accelerating sales of QUVIVIQ across Europe, a promising new addition to insomnia treatments.

QUVIVIQ has been highlighted in the European Sleep Research Society’s guidelines as a significant advancement in insomnia pharmacotherapy. The product’s efficacy and safety have been well-documented, reinforcing our commitment to quality patient care.

Furthermore, our treatment aprocitentan has received approval for uncontrolled hypertension, offering new hope to patients battling this condition. This first-in-class medication, easy to prescribe, is aimed at making a real difference in patient management.

Strategic Partnerships and Growth

As Idorsia continues to grow, we are actively seeking partnerships to fund product launches and develop our pipeline. In 2024, we licensed selatogrel and cenerimod to Viatris, representing a collaborative effort to enhance our R&D capabilities while securing vital milestones for our stakeholders.

The dedication of our management and board has led us through challenging times, focusing on securing partnerships that will yield maximum value for our innovations.

CEO Insights on Progress and Future Directions

Dear Shareholders,

As I step into my role as CEO, I've been met with immense talent and commitment within our global team. Reflecting on the past year, our primary objective remains to keep Idorsia operational while pursuing valuable partnerships.

Key developments include entering a global agreement with Viatris for the joint development of selatogrel and cenerimod, which ensures continued progress while protecting shareholder value.

Despite some setbacks with aprocitentan, we are optimistic as we seek alternative paths to maximize its potential. Our sales performance for QUVIVIQ has been promising, especially in the EUCAN region, where we've witnessed the distribution of over 15 million tablets, helping many achieve improved sleep quality.

Innovation and Development Focus

In the U.S., we aim to adapt our marketing strategies to drive QUVIVIQ's sales and elevate awareness among practitioners. Additionally, the approval of TRYVIO marks a crucial milestone in our commitment to addressing resistant hypertension.

Our research and development strategy has been streamlined to enhance focus and efficiency. Projects are being rigorously prioritized to maximize impact while ensuring we maintain financial sustainability.

Idorsia’s Vision for the Future

With a robust pipeline and exciting partnerships, Idorsia is positioned for significant milestones in the coming years. Our goal remains clear: to become financially sustainable, achieving profitability with QUVIVIQ by 2026.

Our commitment to pushing the boundaries of medical science will continue to guide our path forward. I am grateful for your unwavering support as we work together to transform patient care and uphold our vision at Idorsia.

Sincerely,
André C. Muller
Chief Executive Officer

Frequently Asked Questions

What is the main focus of Idorsia's Annual Report 2024?

The Annual Report outlines Idorsia's accomplishments, financial results, and future strategies, highlighting advancements in products like QUVIVIQ and aprocitentan.

How does Idorsia plan to achieve commercial profitability?

Idorsia aims to achieve commercial profitability with QUVIVIQ by 2026 through strategic partnerships and optimized marketing efforts.

What are the key partnerships established by Idorsia?

Idorsia has partnered with Viatris for the development of selatogrel and cenerimod to enhance research and development efforts.

What is the significance of aprocitentan for Idorsia?

Aprocitentan addresses uncontrolled hypertension, offering a new treatment option and targeting a previously unaddressed pathway in chronic hypertension.

What are the expectations for QUVIVIQ in the EUCAN region?

QUVIVIQ has shown strong sales growth and is expected to solidify a leading position in the EUCAN region for insomnia treatment.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Commodity Rout Tests a Market Already Short on Nerve

Updated Category News Views 95

Some weeks the tape merely wobbles; this one started throwing furniture. By midday Wednesday, traders were staring at sharp declines in gold, silver, crude and copper while the major equity benchmarks remained underwater for the week. That is an unpleasant combination. When growth-sensitive commodities and the usual hard-asset hiding places are all getting sold,...

Continue Reading
Five SEAL Medal of Honor Signatures, One Charity Lot

Updated Category News Views 35

A single rifle can carry a staggering amount of meaning when the names on it belong to all five living U.S. Navy SEAL Medal of Honor recipients. Rock Island Auction Company plans to offer that one-of-a-kind custom precision rifle during its December 4–6, 2026 Premier Firearms Auction, and the financial arrangement is unusually clean: 100% of proceeds are slated for the...

Continue Reading
AI Search Is Squeezing Clicks, Not Killing Content Yet

Updated Category News Views 121

A search result that answers the question before earning a click is a nasty little disruption, and marketers are plainly feeling around for solid ground. Goodfirms surveyed 192 content marketing professionals for its 2026 Content Engagement Metrics report, and the headline is more resilient than the prevailing panic: 66.3% said organic website traffic grew over the prior...

Continue Reading
Tigerlily Takes Its Advocacy Model to Ovarian Cancer

Updated Category News Views 136

Ovarian cancer has a nasty habit of hiding behind symptoms people are taught to shrug off. Persistent bloating or pelvic pain can look like any number of ordinary problems, and that ambiguity is exactly why practical, trusted education matters. Tigerlily Foundation's new ovarian cancer initiative is not a flashy breakthrough claim. It is a grounded attempt to help women...

Continue Reading
Africa’s Digital Ownership Debate Gets More Serious

Updated Category News Views 70

Ownership was the uncomfortable word hanging over Cape Town on day two of Africa Tech Festival 2026, and frankly it should make investors sit up. Africa’s digital economy has no shortage of big promises, shiny AI demos or overseas executives talking about opportunity. The harder question is who funds the pipes, owns the data, makes the rules and actually keeps the...

Continue Reading
YPF’s 2027 Reserves Platform Move Deserves Attention

Updated Category News Views 123

Reservoir software rarely makes anyone pound the table, but this one deserves a hard look. YPF, Argentina’s largest oil and gas company, says it will begin deploying Ikon Science’s MOSAIC reserves planning and management platform in 2027. That is not a new well, a pipeline expansion, or a barrel-count upgrade. It is the machinery behind the machinery: the systems used...

Continue Reading
LiberNovo's European Black Friday Sale Tests Demand

Updated Category News Views 155

A €1,339 chair has no business pretending it is an impulse buy, which is exactly why LiberNovo’s Black Friday push deserves a closer look. The Hong Kong-based ergonomic-chair seller has rolled out its Black Friday sale across the European Union and United Kingdom, with the campaign ending November 30 at 23:59 CET in the EU and 23:59 GMT in the UK. This is a...

Continue Reading
SAFE Wins Missouri Guard UH-60 Platform Contract Again

Updated Category News Views 96

Helicopter maintenance is one of those businesses where a few feet of floor space can matter more than a glossy brochure full of promises. SAFE Structure Designs has landed a new contract to supply custom wraparound maintenance platforms for UH-60 helicopters at the Missouri Army National Guard facility in Springfield, Missouri. No price was disclosed, no delivery...

Continue Reading
Arbor Realty's Loan Mess Meets a Dividend Shutdown

Updated Category News Views 111

A dividend suspension lands differently when the loan book is already coughing up smoke. Arbor Realty Trust’s latest disclosed numbers are not the sort that investors can shrug off as one ugly quarter and forget by Friday. The company reported a third-quarter 2026 GAAP net loss of $85.4 million, suspended its quarterly cash dividend effective immediately, and described...

Continue Reading
Robert Half's Parent Support Earns Fortune Recognition

Updated Category News Views 39

A workplace award rarely moves a staffing stock by itself, and it shouldn’t. Still, Fortune naming Robert Half among its Best Workplaces for Parents for 2026 is more than decorative corporate wallpaper. In the talent business, the company’s own ability to recruit, retain and support people is part of the product. Clients hire Robert Half because they need skilled...

Continue Reading

Top 5 Most Recently Viewed Articles

Helium One Global Ltd Advances Development Drilling Project

Updated Category News Views 381

Helium One Global Ltd Advances Development Drilling Project Helium One Global Ltd (LON: HE1H) (AIM: HE1), a notable helium exploration firm, has embarked on a significant journey with its development drilling at the Galactica-Pegasus project. This project, indicating Helium One's ambition to be a prominent figure in the helium sector, is located in Las Animas County,...

Continue Reading
FieldRoutes Introduces Innovative Features for Service Businesses

Updated Category News Views 77

FieldRoutes Enhances Service Management with Bundles Field service businesses are constantly seeking innovative ways to improve efficiency and customer satisfaction, and at the recent PestWorld conference, FieldRoutes stepped up to the plate. This leading cloud-based and mobile SaaS provider has unveiled its exciting new Bundles feature, aimed at elevating service...

Continue Reading
Exciting Updates on JLT Mobile Computers' Upcoming Meeting

Updated Category News Views 289

Invitation to the Annual General Meeting of JLT Mobile Computers JLT Mobile Computers AB (publ) is inviting its valued shareholders to participate in the Annual General Meeting (AGM). This significant event is set to take place on a Wednesday at 4:00 pm at PM & Vänner Hotel. Eligibility to Attend the Meeting To attend the meeting, it is essential that shareholders are...

Continue Reading
Ambius Collaborates to Transport Historic Trees for Remembrance

Updated Category News Views 214

Ambius Partners in an Environmental Tribute Ambius, a well-known provider of interior landscaping and plant services, has joined hands with the Anne Frank Center USA to undertake an inspiring project. This collaboration involves transporting sapling trees that are direct descendants of the historic horse chestnut tree that grew outside of Anne Frank's hiding spot. These...

Continue Reading
Caterpillar Foundation Celebrates $1 Billion in Charitable Impact

Updated Category News Views 259

Caterpillar Foundation Reaches $1 Billion Global Giving Milestone Since its inception, the Caterpillar Foundation has made remarkable strides in philanthropy, aiding over 11,000 charities across diverse regions. Recently, it achieved an inspiring milestone by surpassing $1 billion in global donations. This achievement underscores the Foundation's steadfast commitment to...

Continue Reading